Matthew Herper on Muck Rack

Matthew Herper Verified

New York
Senior Editor — Forbes
As seen in:  Forbes

Forbes reporter covering science and medicine

Drop That Burger — Patrick O. Brown, a Stanford University biochemist, has changed science twice by giving stuff away. In the early 1990s Brown invented the DNA microarray, a tool that measures how cells make use of their DNA; he then showed researchers how to make their own, transforming genetic research.
Oct 07, 2015

The meat substitutes are coming. Impossible Foods Raises $100M My 2009 profile of founder:…

Express Scripts Says It Will Save America Money On New Cholesterol Drugs, But Its Math Doesn't Check Out — Express Scripts, the country's largest pharmacy benefits manager, says it is dramatically cutting the amount that new, pricey cholesterol-lowering drugs will cost the large employers that employ it to manage their drug costs. But Express Scripts own estimates of those costs are incredibly high. The new medicines, Praluent, made by Tarrytown, [...]
Oct 07, 2015

If someone tells you $ESRX deal signals big market for $REGN $AMGN, don't believe it:…

Oct 07, 2015

Also, ICYMI, if someone tells you a drug is going to bankrupt the system, check their math.…

Company Run By 30-Year-Old Former Hedge Fund Manager Starts Study To Get Its Alzheimer's Drug Approved — Axovant Sciences, the Alzheimer's startup founded by former hedge fund manager Vivek Ramaswamy, announced this morning that it has begun a 1,150-patient study aimed at getting RVT-101, the Alzheimer's drug that the company purchased from GlaxoSmithKline, approved by the Food and Drug Administration. In another positive step for the company, Axovant [...]

Drug Price Demagoguery Could Hurt Patients — When lawmakers demagogue the price issue alone with talk of price caps and controls, markets crash, money for innovative cures dries up, clinical trials get pushed off, and people waiting for cures actually die.
Oct 05, 2015

Price controls and creeping nationalization can't be the answer to regulations-induced irrational drug pricing.…

Here's How We'll Get Cheap Medicine To Poor Countries — What's needed are social business programs - or innovative business models that build local, sustainable capabilities - which create an impact for society that can endure over time.

Real Precision Medicine Requires Real Access To Patient Data — Patient data empowers patients to manage their own personal journeys, and it is also crucial to research because when compiled, it can help facilitate a new generation of hypotheses, new targets and therapeutic approaches.

Gates Foundation Backs New Shot To Prevent Babies From Dying Of Pneumonia — When Bill Gates first became interested in vaccines, he became obsessed with one fact: that it took a decade or more after a vaccine became available in rich countries before it reached children in poor ones. Now Gates' foundation is introducing a new tool for closing that gap. The Bill and [...]

On 60 Minutes, Donald Trump Accidentally Proposes Radical Reform Of U.S. Healthcare — In an interview with 60 Minutes, America's most-watched television news magazine, Donald Trump, America's most-watched presidential candidate, basically just promised that he can defy gravity. I'm not talking about his vow that he could reduce taxes on the middle class -- for some people, rates would go down to zero!
Sep 28, 2015

RT @batchelorshow: sounds a lot more like a traditionally Democratic plan than a Republican one.…

Sep 28, 2015

this happened last night: Donald Trump Accidentally Proposes Radical Reform Of U.S. Healthcare…

What We Should Learn From Pharma's Latest Monster — Martin Shkreli, chief investment officer of MSMB Capital Management, sits behind a chess board in New York, U.S., on Wednesday, Aug. 10, 2011. MSMB made an unsolicited $378 million takeover bid for Amag Pharmaceuticals Inc. and said it will fire the drugmaker's top management if successful. Photographer: Paul Taggart/Bloomberg ***Local [...]
Sep 24, 2015

My Lunch With Shkreli: What We Should Learn From Pharma's Latest Monster - Forbes…

Show 13 more tweets from Maggie Koerth-Baker, Maggie Koerth-Baker and others...

Even After Price Cut, Martin Shkreli Wins — Martin Shkreli. Photographer: Paul Taggart/Bloomberg Everyone's taking the wrong message from the interview Martin Shkreli, the 32-year-old CEO who increased the price of a drug to treat infections in HIV patients by 5,000%, gave last night. People think he's cutting the price, and the American public won. It's more the other way [...]
More Articles →
Oct 09, 2015

RT @RyonGraf: @matthewherper playing devils advocate, authors assume aggressive tumor phenotype develops over time, not innately at carcinogenesis

Oct 09, 2015

RT @CliftonLeaf: From Philly to Oakland, here are this year's 100 fastest-growing inner city companies

Oct 09, 2015

Childcare now costs more than rent. No wonder more women are opting out of the workforce via @FortuneMagazine

Oct 09, 2015

$BIIB team George Scangos, Doug Williams (left), and Tony Kingsley (departed today) in happier times:…

Oct 09, 2015

RT @ewanbirney: Ugh. It made the front of metro. Interestingly underplayed the epigenetics bit. Some caution at end of article.

Are You a Journalist?

Make a Portfolio

Create a free Muck Rack account to customize your profile and upload a portfolio of your best work.